P1108: HIGH COMPLETE RESPONSE RATE FOLLOWING POINT-OF-CARE ANTI CD19 CAR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA. (23rd June 2022) - Fried, S.; Besser, M. J.; Shkury, E.; Yerushalmi, R.; Shem-Tov, N.; Danylesko, I.; Jacoby, E.; Itzhaki, O.; Shouval, R.; Kedmi, M.; Shimoni, A.; Nagler, A.; et al.